Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Lodo Therapeutics Corporation was a drug discovery and development company that specialized in identifying novel therapeutic candidates from microbial natural products found in previously unculturable organisms. Utilizing a proprietary genomics-based platform, Lodo aimed to unlock nature's 'dark matter' to find new medicines for a range of diseases, including challenging infections and cancers. The company was acquired by Zymergen in May 2021, which was subsequently acquired by Ginkgo Bioworks.
The New York headquarters served as the central hub for research and development, laboratory operations, corporate strategy, and business administration prior to its acquisition.
Located in the Alexandria Center for Life Science, a premier urban campus for life science companies, offering state-of-the-art laboratory facilities and fostering a collaborative R&D environment.
As a research-intensive biotech, Lodo likely fostered a highly innovative, science-driven, and collaborative work culture. Employees were focused on cutting-edge genomic and microbiological research with a mission to discover novel therapeutics.
The headquarters' location within a major U.S. biotech hub provided access to top scientific talent, research institutions, potential partners, and investors.
Prior to its acquisition, Lodo Therapeutics Corporation's operations were primarily based in the United States. Its research into microbial diversity had global implications, potentially involving sample collection or collaborations on an international scale, but it did not maintain significant physical office presences globally.
430 East 29th Street, 14th Floor
New York
NY
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Lodo Therapeutics Corporation' leadership includes:
Lodo Therapeutics Corporation has been backed by several prominent investors over the years, including:
Lodo Therapeutics Corporation was acquired by Zymergen in May 2021, which was subsequently acquired by Ginkgo Bioworks. Therefore, there have been no executive hires or exits for Lodo Therapeutics as an independent entity in the last 12 months. Leadership transitions occurred as part of these acquisitions.
Discover the tools Lodo Therapeutics Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Lodo Therapeutics Corporation likely utilized common corporate email formats. Given its acquisition, emails to @lodotherapeutics.com are unlikely to be active.
[first_initial][last]@lodotherapeutics.com (e.g., jsmith@lodotherapeutics.com) or [first].[last]@lodotherapeutics.com (e.g., john.smith@lodotherapeutics.com)
Format
dphost@lodotherapeutics.com (example based on former CEO)
Example
0%
Success rate
PR Newswire (via Zymergen) • May 11, 2021
Zymergen Inc. announced its acquisition of Lodo Therapeutics Corporation. The acquisition was intended to integrate Lodo's pioneering drug discovery platform with Zymergen's synthetic biology expertise to develop novel products....more
Lodo Therapeutics Press Release / FierceBiotech • September 18, 2018
Lodo Therapeutics announced the completion of a $17 million Series A financing round. The funding was co-led by ARCH Venture Partners and included significant participation from AbbVie Ventures, Alexandria Venture Investments, an affiliate of The Bill & Melinda Gates Foundation, and others, to advance its genomics-based drug discovery platform....more
Lodo Therapeutics Press Release / Business Wire • January 9, 2017
Lodo Therapeutics Corporation officially launched its operations with significant seed investment to develop its platform for discovering novel therapeutics by accessing the vast chemical diversity encoded in microbial DNA....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Lodo Therapeutics Corporation, are just a search away.